Restricted Mean Survival Time: An Obligatory End Point for Time-to-Event Analysis in Cancer Trials?

MLA

A’Hern, Roger P. “Restricted Mean Survival Time: An Obligatory End Point for Time-to-Event Analysis in Cancer Trials?” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 34, no. 28, Oct. 2016, pp. 3474–76. EBSCOhost, https://doi.org/10.1200/JCO.2016.67.8045.

APA

A’Hern, R. P. (2016). Restricted Mean Survival Time: An Obligatory End Point for Time-to-Event Analysis in Cancer Trials? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 34(28), 3474–3476. https://doi.org/10.1200/JCO.2016.67.8045

Chicago

A’Hern, Roger P. 2016. “Restricted Mean Survival Time: An Obligatory End Point for Time-to-Event Analysis in Cancer Trials?” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 34 (28): 3474–76. doi:10.1200/JCO.2016.67.8045.